Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country
- PMID: 23936052
- PMCID: PMC3720588
- DOI: 10.1371/journal.pone.0069581
Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country
Abstract
Community-acquired urinary tract infection (CA-UTI) is the most common infection caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, but the clinical epidemiology of these infections in low prevalence countries is largely unknown. A population based case-control study was conducted to assess risk factors for CA-UTI caused by ESBL-producing E. coli or K. pneumoniae. The study was carried out in a source population in Eastern Norway, a country with a low prevalence of infections caused by ESBL-producing Enterobacteriaceae. The study population comprised 100 cases and 190 controls with CA-UTI caused by ESBL-producing and non-ESBL-producing E. coli or K. pneumoniae, respectively. The following independent risk factors of ESBL-positive UTIs were identified: Travel to Asia, The Middle East or Africa either during the past six weeks (Odds ratio (OR) = 21; 95% confidence interval (CI): 4.5-97) or during the past 6 weeks to 24 months (OR = 2.3; 95% CI: 1.1-4.4), recent use of fluoroquinolones (OR = 16; 95% CI: 3.2-80) and β-lactams (except mecillinam) (OR = 5.0; 95% CI: 2.1-12), diabetes mellitus (OR = 3.2; 95% CI: 1.0-11) and recreational freshwater swimming the past year (OR = 2.1; 95% CI: 1.0-4.0). Factors associated with decreased risk were increasing number of fish meals per week (OR = 0.68 per fish meal; 95% CI: 0.51-0.90) and age (OR = 0.89 per 5 year increase; 95% CI: 0.82-0.97). In conclusion, we have identified risk factors that elucidate mechanisms and routes for dissemination of ESBL-producing Enterobacteriaceae in a low prevalence country, which can be used to guide appropriate treatment of CA-UTI and targeted infection control measures.
Conflict of interest statement
Figures
Similar articles
-
Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.Turk J Med Sci. 2019 Aug 8;49(4):1206-1211. doi: 10.3906/sag-1902-24. Turk J Med Sci. 2019. PMID: 31385490 Free PMC article.
-
Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.Int J Antimicrob Agents. 2017 Aug;50(2):197-202. doi: 10.1016/j.ijantimicag.2017.03.009. Epub 2017 May 24. Int J Antimicrob Agents. 2017. PMID: 28552471
-
High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.PLoS One. 2014 Jan 15;9(1):e85889. doi: 10.1371/journal.pone.0085889. eCollection 2014. PLoS One. 2014. PMID: 24454943 Free PMC article.
-
Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae.Pediatr Infect Dis J. 2019 Dec;38(12):e332-e335. doi: 10.1097/INF.0000000000002487. Pediatr Infect Dis J. 2019. PMID: 31738343 Review. No abstract available.
-
Increasing Prevalence of Pediatric Community-acquired UTI by Extended Spectrum β-Lactamase-producing E. coli: Cause for Concern.Pediatr Infect Dis J. 2023 Feb 1;42(2):106-109. doi: 10.1097/INF.0000000000003777. Epub 2022 Nov 15. Pediatr Infect Dis J. 2023. PMID: 36638394 Review.
Cited by
-
Diabetes, SGLT-2 Inhibitors, and Urinary Tract Infection: a Review.Curr Diab Rep. 2024 Mar 1. doi: 10.1007/s11892-024-01537-3. Online ahead of print. Curr Diab Rep. 2024. PMID: 38427314 Review.
-
One Health Determinants of Escherichia coli Antimicrobial Resistance in Humans in the Community: An Umbrella Review.Int J Mol Sci. 2023 Dec 6;24(24):17204. doi: 10.3390/ijms242417204. Int J Mol Sci. 2023. PMID: 38139033 Free PMC article. Review.
-
Spatial clusters of extended-spectrum beta-lactamase-producing Escherichia coli causing community-onset bacteriuria due to repeat infections: cluster analysis from a large urban medical center, San Francisco, 2014-2020.Antimicrob Resist Infect Control. 2023 Oct 20;12(1):115. doi: 10.1186/s13756-023-01320-1. Antimicrob Resist Infect Control. 2023. PMID: 37858209 Free PMC article.
-
Detection of blaCTX-M and blaDHA genes in stool samples of healthy people: comparison of culture- and shotgun metagenomic-based approaches.Front Microbiol. 2023 Aug 31;14:1236208. doi: 10.3389/fmicb.2023.1236208. eCollection 2023. Front Microbiol. 2023. PMID: 37720151 Free PMC article.
-
Case report: A successfully treated case of community-acquired urinary tract infection due to Klebsiella aerogenes in Bangladesh.Front Med (Lausanne). 2023 Jun 26;10:1206756. doi: 10.3389/fmed.2023.1206756. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37435536 Free PMC article.
References
-
- Pitout JD, Laupland KB (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8: 159–166. - PubMed
-
- Rottier WC, Ammerlaan HS, Bonten MJ (2012) Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother 67: 1311–1320. - PubMed
-
- Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, et al. (2009) A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 49: 682–690. - PubMed
-
- Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD (2008) Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect 57: 441–448. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
